Negative emotionality shapes the modulatory effects of ketamine and lamotrigine in subregions of the anterior cingulate cortex.
Matti GärtnerAnne WeigandMarvin Sören MeieringDavid WeignerLuisa CarstensChristian KeicherRita HertrampfChristian BeckmannMaarten MennesAndreas WunderSimone GrimmPublished in: Translational psychiatry (2024)
Neuroimaging studies have identified the anterior cingulate cortex (ACC) as one of the major targets of ketamine in the human brain, which may be related to ketamine's antidepressant (AD) mechanisms of action. However, due to different methodological approaches, different investigated populations, and varying measurement timepoints, results are not consistent, and the functional significance of the observed brain changes remains a matter of open debate. Inhibition of glutamate release during acute ketamine administration by lamotrigine provides the opportunity to gain additional insight into the functional significance of ketamine-induced brain changes. Furthermore, the assessment of trait negative emotionality holds promise to link findings in healthy participants to potential AD mechanisms of ketamine. In this double-blind, placebo-controlled, randomized, single dose, parallel-group study, we collected resting-state fMRI data before, during, and 24 h after ketamine administration in a sample of 75 healthy male and female participants who were randomly allocated to one of three treatment conditions (ketamine, ketamine with lamotrigine pre- treatment, placebo). Spontaneous brain activity was extracted from two ventral and one dorsal subregions of the ACC. Our results showed activity decreases during the administration of ketamine in all three ACC subregions. However, only in the ventral subregions of the ACC this effect was attenuated by lamotrigine. 24 h after administration, ACC activity returned to baseline levels, but group differences were observed between the lamotrigine and the ketamine group. Trait negative emotionality was closely linked to activity changes in the subgenual ACC after ketamine administration. These results contribute to an understanding of the functional significance of ketamine effects in different subregions of the ACC by combining an approach to modulate glutamate release with the assessment of multiple timepoints and associations with trait negative emotionality in healthy participants.
Keyphrases
- resting state
- functional connectivity
- pain management
- double blind
- placebo controlled
- spinal cord
- clinical trial
- genome wide
- randomized controlled trial
- mass spectrometry
- squamous cell carcinoma
- minimally invasive
- dna methylation
- phase iii
- intensive care unit
- risk assessment
- machine learning
- radiation therapy
- white matter
- study protocol
- spinal cord injury
- liver failure
- artificial intelligence
- neuropathic pain
- prefrontal cortex
- human health